Cempra, Inc.

6320 Quadrangle Dr
Chapel Hill, NC 27517

Cempra, Inc. News

Cempra receives $16M from BARDA for drug study

Friday, Nov 21, 2014 @ 1:55pm by BioPrepWatch Reports

Cempra Inc. announced on Thursday that is will receive an additional $16 million from the Biomedical Advanced Research and Development Authority (BARDA) for two more clinical studies of its drug solithromycin on pediatric patients with bacterial infections.
Read More »